Suitability of NIID‐MDCK cells as a substrate for cell‐based influenza vaccine development from the perspective of adventitious virus susceptibility-Reference-Cited by-同舟云学术

Suitability of NIID‐MDCK cells as a substrate for cell‐based influenza vaccine development from the perspective of adventitious virus susceptibility

Published:2022-06-08 Issue:7 Volume:66 Page:361-370
ISSN:0385-5600
Container-title:Microbiology and Immunology
language:en
Short-container-title:Microbiology and Immunology

Author:

Hamamoto Itsuki¹,Takahashi Hitoshi¹,Shimasaki Noriko¹,Nakamura Kazuya¹,Mizuta Katsumi²,Sato Ko³,Nishimura Hidekazu³,Yamamoto Norio¹⁴,Hasegawa Hideki¹,Odagiri Takato¹,Tashiro Masato¹,Nobusawa Eri¹^ORCID

Affiliation:

1. Center for Influenza and Respiratory Virus Research National Institute of Infectious Diseases Musashimurayama‐shi Tokyo Japan

2. Yamagata Prefectural Institute of Public Health Yamagata Japan

3. Virus Research Center, Sendai Medical Center National Hospital Organization Sendai Japan

4. Department of Microbiology Tokai University School of Medicine Isehara Kanagawa Japan

Funder

Japan Agency for Medical Research and Development

Publisher

Wiley

Subject

Virology,Immunology,Microbiology

Link

https://onlinelibrary.wiley.com/doi/pdf/10.1111/1348-0421.12985

Reference30 articles.

1. Low 2012–13 Influenza Vaccine Effectiveness Associated with Mutation in the Egg-Adapted H3N2 Vaccine Strain Not Antigenic Drift in Circulating Viruses

2. Influenza immunization elicits antibodies specific for an egg-adapted vaccine strain

3. Contemporary H3N2 influenza viruses have a glycosylation site that alters binding of antibodies elicited by egg-adapted vaccine strains

4. A structural explanation for the low effectiveness of the seasonal influenza H3N2 vaccine

5. Cell culture-derived influenza vaccines in the severe 2017–2018 epidemic season: a step towards improved influenza vaccine effectiveness

Cited by 3 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Evaluation of a qualified MDCK cell line for virus isolation to develop cell-based influenza vaccine viruses with appropriate antigenicity;Vaccine;2024-10

2. Innovations in cell culture-based influenza vaccine manufacturing – from static cultures to high cell density cultivations;Human Vaccines & Immunotherapeutics;2024-07-15

3. Developments and current challenges in the process of cell culture-based seasonal influenza vaccine manufacture in Japan;Global Health & Medicine;2024-04-30